Patrys Ltd (ASX: PAB) Share Price and News

Dr Campbell has more than 20 years of international biotechnology research, management and leadership experience and has been involved in the creation and/or transformation of multiple successful Australian and international biotechnology companies. Dr. Campbell was a foundation executive of Evolve Biosystems, and has assisted private biotechnology companies in Australia, New Zealand and the USA with capital raising and partnering negotiations. Dr. Campbell sits on the Board of AusBiotech, Australia's peak industry body for biotechnology

Mr Stork was the Managing Director of Stork Holdings Ltd, an Investment Holding company active in the Canadian technology start-up sector.Mr. Stork was on the Board of Governors of the University of Waterloo and is the Chair of the Waterloo Accelerator Centre, a technology company incubator affiliated with the University.He was the Chair of Spartan Biosciences Inc.,an Ottawa based DNA analytics company,the Chair of Dejero Labs Inc. a Waterloo based broadcast technology company,and active on the Boards of a number of other leading Canadian technology start-up companies.He is Chair of Risk Committee.

Mr Ross has over 10 years of experience in accounting and secretarial services for ASX listed companies. His experience includes ASX compliance, corporate governance control and implementation, statutory financial reporting, shareholder meeting requirements, capital raising management, and board and secretarial support.

Dr Klein has a track record as an executive over more than 20 years in the oncology and biopharmaceutical industry. She is currently on the Board of Directors for Argenx, a dual-listed (Euronext Brussels and NASDAQ), clinical-stage therapeutic antibody company developing novel drugs in severe autoimmune disease. She is also on the Board of IMab, F-Star,Sardona and ONA. Dr. Klein is the Principal and Founder of PMK BioResearch, which offers strategic consulting in oncology drug development.

Dr Gittleson is the former Chief Medical Officer of CSL Limited with more than 20 years of experience in pharmaceutical development in Australia and the USA.Dr. Gittleson's spans many aspects of the pharmaceutical industry, from drug development and clinical research through to strategic planning and executive management.Dr. Gittleson has been involved in drug development programs across a wide range of different therapeutic areas, and has worked with regulators in key markets such as the US,EU,Asia Pacific,Japan and South America.where she has been actively involved in strategy development, capital raising and Board renewal.He is Member of risk Committee.

-

-

-